News | May 13, 2025
Morepen Laboratories reports Q4 FY25 consolidated PAT at Rs. 20.31 Cr
The company has posted net profit of Rs. 118.01 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 118.01 crores for the Financial Year ended March 31, 2025
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
AstraZeneca Pharma India discontinues manufacturing of Imdur
Empamore is poised to make a significant impact by offering high-quality treatment at an affordable price point, empowering millions of Indians to take control of their health
Morepen Laboratories approves hiving off of medical devices business
Morepen Labs successfully raised Rs. 200 Crore through QIP
Sharma joined the Morepen Lab in 2004
Morepen Laboratories has reported total income of Rs. 448.62 crores during the period ended December 31, 2023
Morepen Laboratories has reported total income of Rs. 425 crores during the quarter ended September 30, 2023
The company is addressing these observations
Subscribe To Our Newsletter & Stay Updated
